← Open Payments lookup

CHRISTOPHER MORACHE: Open Payments

NPI 1689621567 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,657 in 72 payments from 14 companies in 2025. Trend: 2023 $1,117 · 2024 $2,187 · 2025 $1,657

Food & beverage: $1,657
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$404
E.R. Squibb & Sons, L.L.C.12$256
ABBVIE INC.9$160
Supernus Pharmaceuticals, Inc.7$152
Otsuka America Pharmaceutical, Inc.10$149
Janssen Pharmaceuticals, Inc4$112
Alkermes, Inc.4$83
Vanda Pharmaceuticals Inc.3$82
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
Almatica Pharma LLC3$63

Products named: INGREZZA, COBENFY, REXULTI, Qelbree, VRAYLAR, ARISTADA, FANAPT, SPRAVATO.

Industry payments across CA — which companies pay providers there.